GLP-1 Zepbound is approved as first drug for sleep apnea

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.

Leave A Comment

Your email address will not be published. Required fields are marked *